CIK 0001001233 · Non-accelerated filer<br>Smaller reporting company
SANGAMO THERAPEUTICS, INC
Sign in to watch- Ticker
- SGMOQ
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680359556
- Phone
- 5109706000
- Business address
- 501 CANAL BLVD., RICHMOND, CA, 94084
- Former names
- SANGAMO BIOSCIENCES INC
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- DEFR14A Other DEFR14A
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- CT ORDER Other Confidential Order
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Bylaws or fiscal year change
- UPLOAD Other SEC-generated Letter
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- POSASR Other POSASR
- SC 13G Stake Amended Statement of Ownership
Page 36 of 81 · 1,615 filings